Today, CTTI’s Director of Stakeholder Engagement Bray Patrick-Lake joins colleagues at the FDA Clinical Outcome Assessments Public Workshop to discuss accomplishments, challenges, and ongoing efforts in the use of clinical outcome assessments (COAs). Additionally, they group will plan for the future of COA development and utilization in drug development programs, including how to incorporate the patient voice in drug development using well-defined and reliable patient-centered outcome measures. To view the meeting materials, including agenda and background documents, click here.

For a complete list of CTTI’s upcoming events, click here.